Page 716 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 716

Hemodialysis and Extracorporeal Blood Purification  703


            which the predialysis serum potassium is greater than  clearance of the toxin or its metabolites, or there is no
            6.0 mmol/L, a dialysate containing 0 mmol/L of potas-  specific antidote for the toxicant. Hemodialysis can be
            sium has been recommended. 34,38,59  Transfer of potas-  used to eliminate toxins from the body before they pro-
            sium from secluded intracellular pools may lag behind  mote cellular damage or before they are converted to
            its rate of removal from the extracellular compartment  more toxic metabolites. The dialytic removal of exoge-
            by the dialyzer, causing transient hypokalemia at the  nous toxins is governed by the same molecular
            end of dialysis sessions.  136  A rebound hyperkalemia  characteristics that define dialytic clearance of endoge-
            occurs following the delayed transfer from intracellular  nous toxins. Molecular size, concentration in plasma
            pools within hours of ending dialysis that extends to  water, distribution volume, degree of protein binding,
            the next dialysis treatment. Daily dialysis may be required  and lipid solubility significantly influence the potential
            until the bulk of the potassium burden is corrected.  for a toxin’s elimination. 14,161,185  Toxins or drugs with
              In contrast to medical treatments for hyperkalemia,  low-molecular-weights (<1500 Da), small volumes of
            which merely shift extracellular potassium to intracellular  distribution, and minimal protein binding are excellent
            pools or antagonize its neuromuscular toxicity, hemodi-  candidates for diffusive and convective clearance. A small
            alysis eliminates excessive potassium loads from both  volume of distribution (<1.0 L/kg) predicts the toxin is
            extracellular and intracellular pools. 134  Additional  protein-bound or restricted to the extracellular space and
            guidelines for the dialytic management of hyperkalemia  accessible for extracorporeal clearance. A toxin with a
            were discussed previously under the Hemodialysis Pre-  large distribution volume (>1.0 L/kg) is likely to be
            scription for Acute Kidney Injury section.          concentrated in tissues and will have minimal transference
              The dialysate sodium concentration can be propor-  or availability in plasma water for removal. Only the free
            tioned  to  concentrations  ranging  from  125  to  fraction of protein-bound toxins can be dialyzed readily,
            160 mmol/L. It also can be programmed (or profiled)  and toxins or drugs that are highly protein bound may
            to change in user-defined patterns throughout the dialy-  not be good candidates for dialytic removal.
            sis session to achieve specific treatment goals or to correct  Ethylene glycol has a molecular weight of 62 Da,
            predialysis dysnatremias. Hyponatremia caused by    negligible protein binding, and a volume of distribution
            sodium losses from excessive vomiting, diarrhea, diuretic  equivalent to total body water (0.5 to 0.8 L/kg) and con-
            administration, parenteral sodium-free fluid administra-  sequently is an excellent candidate for dialytic removal.
            tion, or oral water can be corrected by programming  With timely dialysis, ethylene glycol can be removed from
            the dialysate sodium concentration to increase in stepped  the body before its enzymatic oxidation to more toxic
            increments or continuous gradients to the desired   metabolites,  including  glycoaldehyde,  glycolate,
            postdialysis concentration. Hypernatremia caused by  glyoxylate,andoxalate. 14,20,34,137,161 Toxinsthatarehighly
            excessive bicarbonate or hypertonic saline administration  bound to serum proteins, including diazepam, salicylates,
            may be difficult or inappropriate to correct with addi-  nonsteroidal antiinflammatory drugs (NSAIDs), and tricy-
            tional fluid administration but can be resolved easily by  clic antidepressants, are dialyzed less effectively, but dialysis
            adjusting the dialysate sodium concentration in progres-  may still be a therapeutic option. Redistribution (rebound)
            sive or incremental steps until the desired sodium concen-  of a toxin or drug from peripheral tissues or cellular
            tration is reached. The rate of correction can be regulated  compartments to plasma may limit the efficacy of dialysis
            precisely without overcorrection. Excessive isonatremic  to resolve the poisoning. If redistribution of the toxin from
            loads of sodium can be eliminated by ultrafiltration alone  extravascular pools is much slower than its dialytic removal,
            without simultaneous changes in serum sodium concen-  the animal may become reintoxicated within hours after
            tration. With the exception of minor Gibbs-Donnan   completing dialysis. For these sequestered toxins, the
            effects, the ultrafiltrate is formed with the same sodium  length and frequency of dialysis may need to be increased
            concentration present in plasma water. Consequently,  to facilitate their whole-body elimination.
            large  sodium  loads  can  be  eliminated  without     Hemoperfusion is an adsorptive extracorporeal therapy
            perturbations in sodium concentration or the risk of  used to manage endogenous and exogenous intoxications
            inducing sodium disequilibrium, which may trigger   thatarenotclearedefficientlybyhemodialysis.Adsorption
            redistribution of fluid and electrolytes from intracellular  is the principle of molecular attachment of a solute to a
            stores. 45,135                                      material surface. In contrast to the physical separation
                                                                between blood and dialysate that occurs during hemodial-
            USE OF HEMODIALYSIS IN ACUTE                        ysis, during hemoperfusion blood is exposed directly
            INTOXICATIONS                                       to an adsorbent with the capacity to selectively or

            Elimination of toxins and support for the consequences  nonselectively bind toxins of defined chemical composi-
            of the intoxication are important but overshadowed  tion within the blood path. Hemoperfusion is a small
            applications of hemodialysis. 20,79,175  This use of hemodi-  but defined niche in medical therapeutics, which should
            alysis is especially important if there has been a delay in  be incorporated more broadly into extracorporeal
            medical management, there is limited endogenous     therapies in veterinary medicine.  20,79,152  Hemoperfusion
   711   712   713   714   715   716   717   718   719   720   721